Sign Up Today and Learn More About Curevo Stock
Invest in or calculate the value of your shares in Curevo or other pre-IPO companies through EquityZen's platform.
Curevo Stock (CUR)
Curevo is a clinical-stage biotech firm that focuses on producing vaccines.
About Curevo Stock
Founded
2018
Headquarters
Bothell, WA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Curevo Press Mentions
Stay in the know about the latest news on Curevo
The Week’s Biggest Funding Rounds: Nerdio Tops Slow Week Of Raises
news • Mar 21, 2025
Curevo gets $110M for a shot against Shingrix, gets Moncef Slaoui and Tal Zaks on board
endpts • Mar 17, 2025
Curevo Raises $110 Million to Advance Amezosvatein Shingles Vaccine
globenewswire • Mar 17, 2025
Curevo Announces Positive Updated Phase 2 Data for Amezosvatein Shingles Vaccine
tradingview • Jan 14, 2025
Curevo Announces Positive Updated Phase 2 Data for Amezosvatein Shingles Vaccine
einpresswire • Jan 14, 2025
Curevo Management
Leadership team at Curevo
CEO
George Simeon
Chief Medical Officer
Guy De La Rosa
Join now and verify your accreditation status to gain access to:
- Curevo Current Valuation
- Curevo Stock Price
- Curevo Management
- Available deals in Curevo and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Curevo Cap Table and Funding History by Share Class and Liquidity Preferences
- Curevo Revenue and Financials
- Curevo Highlights
- Curevo Business Model
- Curevo Risk Factors
- Curevo Research Report from SACRA Research
Trading Curevo Stock
How to invest in Curevo stock?
Accredited investors can buy pre-IPO stock in companies like Curevo through EquityZen funds. These investments are made available by existing Curevo shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Curevo stock?
Shareholders can sell their Curevo stock through EquityZen's private company marketplace. EquityZen's network includes over 370K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
